Canada markets open in 15 minutes

Akero Therapeutics, Inc. (0K4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.85+0.30 (+3.51%)
As of 08:01AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 291.69M
Enterprise Value 136.03M
Trailing P/E 8.45
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.35
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.22

Trading Information

Stock Price History

Beta (5Y Monthly) 0.54
52-Week Change 3-63.15%
S&P500 52-Week Change 3-3.35%
52 Week High 325.20
52 Week Low 38.20
50-Day Moving Average 311.98
200-Day Moving Average 316.84

Share Statistics

Avg Vol (3 month) 315
Avg Vol (10 day) 318
Shares Outstanding 535.02M
Implied Shares Outstanding 6N/A
Float 819.46M
% Held by Insiders 18.71%
% Held by Institutions 1103.35%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Dec 31, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.90%
Return on Equity (ttm)-47.11%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -100.84M
Net Income Avi to Common (ttm)-100.78M
Diluted EPS (ttm)-2.79
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)188.26M
Total Cash Per Share (mrq)5.38
Total Debt (mrq)1.52M
Total Debt/Equity (mrq)0.90
Current Ratio (mrq)7.70
Book Value Per Share (mrq)4.84

Cash Flow Statement

Operating Cash Flow (ttm)-79.68M
Levered Free Cash Flow (ttm)-43.22M